Arcutis Biotherapeutics, Inc.
ARQT • NASDAQ • Stock Fundamentals
Arcutis Biotherapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Todd Franklin Watanabe, with a market cap of $3.1B.
Market Cap$3.1B
Employees296.0
CEOTodd Franklin Watanabe
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Arcutis Biotherapeutics, Inc. FAQ
Common questions about Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. (ARQT) has a market capitalization of $3.1B and trades on NASDAQ.
Arcutis Biotherapeutics, Inc. has approximately 296 employees.